Harleen Anderson
Allergy & Immunology · Winter Park, FLNPI 1821218280
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by AstraZeneca at 48.6% of the total.
Across 594 payments — averaging $50.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$14K
- Galderma Laboratories, L.p.$3K
- ARS Pharmaceuticals Operations, Inc.$3K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$1K
- Pfizer$1K
- plus $5K from 31 others
What the payments were for
- Consulting fees$2,7199%
- Speaking & faculty fees$15,05051%
- Travel & lodging$700%
- Food & beverage$11,71639%
- Education$1741%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 99 | $14,435 |
| Galderma Laboratories, L.p. | 10 | $3,409 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $2,760 |
| Regeneron Healthcare Solutions, Inc. | 79 | $1,569 |
| Sanofi | 60 | $1,259 |
| Pfizer | 64 | $1,084 |
| GSK | 58 | $934 |
| Takeda Pharmaceuticals U.S.A., Inc. | 39 | $816 |
| Optinose US, Inc. | 18 | $393 |
| CSL Behring | 14 | $316 |
| Novartis | 15 | $294 |
| Grifols USA, LLC | 15 | $289 |
| Kaleo, Inc. | 14 | $242 |
| Pharming Healthcare, Inc. | 13 | $214 |
| Alk-abello, Inc | 11 | $184 |
| Genentech USA, Inc. | 10 | $163 |
| Boehringer Ingelheim | 9 | $160 |
| Octapharma USA, Inc. | 3 | $160 |
| Teva Pharmaceuticals USA, Inc. | 10 | $149 |
| Covis Pharma GmbH | 6 | $113 |
| Shire North American Group Inc | 6 | $99 |
| Aimmune Therapeutics, Inc. | 4 | $91 |
| Amgen | 4 | $88 |
| Biocryst US Sales Co., LLC | 5 | $85 |
| Lilly USA, LLC | 3 | $68 |
| Phadia US Inc. | 3 | $59 |
| Insmed, Inc. | 3 | $49 |
| GC Biopharma USA, Inc. | 2 | $41 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| Hikma Pharmaceuticals USA | 2 | $36 |
| Incyte Corporation | 2 | $34 |
| AbbVie | 1 | $22 |
| Cycle Pharmaceuticals Inc | 1 | $20 |
| ADMA Biomanufacturing LLC | 1 | $19 |
| Circassia Inc. | 1 | $18 |
| Merck | 1 | $14 |
| Bio Products Laboratory USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,729 in reported general payments places this provider in the 85th percentile of 204 allergy & immunology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $52,069 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 11 | $46,705 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $31,893 |
| Advair HfaFluticasone Propion/Salmeterol | 22 | $8,177 |
| Arnuity ElliptaFluticasone Furoate | 13 | $3,462 |
| Advair DiskusFluticasone Propion/Salmeterol | 12 | $2,370 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $1,100 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $865 |
| Montelukast Sodium | 81 | $673 |
| Azelastine Hcl | 14 | $551 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Grifols USA, LLCGamunex-C | $289 | $46,70511 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $934 | $35,35656 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 204 allergy & immunology providers in Florida.
Other allergy & immunology in Winter Park
- Dennis LedfordTampa$1.2M
- Nina RamirezMiami$833K
- Thomas WestbrookPensacola$810K
- Shahnaz FattehPlantation$677K
- Thomas CasaleTampa$382K
- Thomas JohnsonGainesville$361K
- Mark GlaumTampa$337K
- Alan HalseyValrico$243K
- Steve DormanJacksonville$208K
- Juan Carlos CardetTampa$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.